Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
focuses on understanding the molecular and cellular mechanisms of systemic amyloid deposition, with particular emphasis on AL and ATTR amyloidosis. We use in situ structural approaches to visualize amyloid
-
We have an exciting research opportunity for a Research Assistant / Associate tojoin our team. The post holder will be based at the Cancer Research UK-Scotland Institute (CRUK-SI) in Glasgow https
-
application instructions), please visit: https://www.mpg.de/en/max-planck-postdoc-program . To submit your application online, please visit: https://postdocprogram.mpg.de The application deadline is April 13
-
Postdoctoral Scholar in Structural Biology & Translational Medicine Are you a structural biologist looking to bridge the gap between fundamental discovery and real-world therapeutic applications
-
A position as post doc in structural biology and biochemistry is available at the Department of Molecular Biology and Genetics, University of Aarhus, Denmark. Expected start date and duration of
-
regulatory RNAs. Characterization of RNA devices by structural biology methods such as cryo-electron microscopy (cryo-EM) and tomography (cryo-ET). Testing and screening of RNA devices by functional assays in
-
includes the following tasks: Develop computer-aided design software for modular construction of switchable RNA nanostructures. Develop databases for RNA modules for automated building of atomistic models
-
information about the Cluster of Excellence can be found at https://theoceanfloor.de . The postdoctoral fellows are invited to develop their own research project aligned with the research portfolio
-
Postdoctoral Positions for Computational Genomics, Cancer Genetics, and Translational Cancer Biology
insights through iterative, hypothesis-driven computational analysis. 2) Characterizing the landscape of structural mutations—including intragenic rearrangements (IGRs)—across cancer types and modeling
-
our publications here . Our team is at the forefront of bringing autologous cell replacement therapies with CRISPR-edited muscle stem cells towards the clinic (https://www.mdc-berlin.de/news/news/deep